Skip to main content

Syndax Pharmaceuticals rating affirmed

Morgan Stanley affirmed its Overweight rating on Syndax Pharmaceuticals Inc. (Nasdaq: SNDX) sending the stock price soaring $3.00 to close at $13.58.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.